248 related articles for article (PubMed ID: 31523055)
1. Aberrations in Notch-Hedgehog signalling reveal cancer stem cells harbouring conserved oncogenic properties associated with hypoxia and immunoevasion.
Chang WH; Lai AG
Br J Cancer; 2019 Oct; 121(8):666-678. PubMed ID: 31523055
[TBL] [Abstract][Full Text] [Related]
2. Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies.
Chang WH; Lai AG
J Transl Med; 2019 Apr; 17(1):132. PubMed ID: 31014368
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional landscape of DNA repair genes underpins a pan-cancer prognostic signature associated with cell cycle dysregulation and tumor hypoxia.
Chang WH; Lai AG
DNA Repair (Amst); 2019 Jun; 78():142-153. PubMed ID: 31054516
[TBL] [Abstract][Full Text] [Related]
4. A novel signature derived from immunoregulatory and hypoxia genes predicts prognosis in liver and five other cancers.
Chang WH; Forde D; Lai AG
J Transl Med; 2019 Jan; 17(1):14. PubMed ID: 30626396
[TBL] [Abstract][Full Text] [Related]
5. An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types.
Chang WH; Lai AG
BMC Cancer; 2020 Aug; 20(1):773. PubMed ID: 32807122
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer genomic amplifications underlie a WNT hyperactivation phenotype associated with stem cell-like features leading to poor prognosis.
Chang WH; Lai AG
Transl Res; 2019 Jun; 208():47-62. PubMed ID: 31028732
[TBL] [Abstract][Full Text] [Related]
7. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
8. The panoramic picture of pepsinogen gene family with pan-cancer.
Shen S; Li H; Liu J; Sun L; Yuan Y
Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
[TBL] [Abstract][Full Text] [Related]
9. Lung squamous cell carcinoma and lung adenocarcinoma differential gene expression regulation through pathways of Notch, Hedgehog, Wnt, and ErbB signalling.
Anusewicz D; Orzechowska M; Bednarek AK
Sci Rep; 2020 Dec; 10(1):21128. PubMed ID: 33273537
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
11. Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways.
Oren O; Smith BD
Stem Cell Rev Rep; 2017 Feb; 13(1):17-23. PubMed ID: 27730468
[TBL] [Abstract][Full Text] [Related]
12. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
[TBL] [Abstract][Full Text] [Related]
13. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
[TBL] [Abstract][Full Text] [Related]
14. The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure.
Galassi C; Musella M; Manduca N; Maccafeo E; Sistigu A
Cells; 2021 Sep; 10(9):. PubMed ID: 34572009
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cell epigenetics and chemoresistance.
Crea F; Danesi R; Farrar WL
Epigenomics; 2009 Oct; 1(1):63-79. PubMed ID: 22122637
[TBL] [Abstract][Full Text] [Related]
16. Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.
Haider S; McIntyre A; van Stiphout RG; Winchester LM; Wigfield S; Harris AL; Buffa FM
Genome Biol; 2016 Jun; 17(1):140. PubMed ID: 27358048
[TBL] [Abstract][Full Text] [Related]
17. The pan-cancer mutational landscape of the PPAR pathway reveals universal patterns of dysregulated metabolism and interactions with tumor immunity and hypoxia.
Chang WH; Lai AG
Ann N Y Acad Sci; 2019 Jul; 1448(1):65-82. PubMed ID: 31215667
[TBL] [Abstract][Full Text] [Related]
18. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
[TBL] [Abstract][Full Text] [Related]
19. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties.
Aoki S; Mizuma M; Takahashi Y; Haji Y; Okada R; Abe T; Karasawa H; Tamai K; Okada T; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Katayose Y; Unno M
BMC Cancer; 2016 Nov; 16(1):854. PubMed ID: 27821106
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.
You Y; Li Y; Li M; Lei M; Wu M; Qu Y; Yuan Y; Chen T; Jiang H
Clin Exp Immunol; 2018 Jan; 191(1):60-73. PubMed ID: 28868628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]